Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
Clinical Schizophrenia & Related Psychoses
|
September 26, 2012
Advantages and limitations of newer antipsychotics: evidence from large comparative trials
L Fredrik Jarskog
Current Opinion in Psychiatry
|
April 14, 2006
Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations
L Fredrik Jarskog
The Journal of Clinical Psychiatry
|
November 4, 2006
Neuroprotection in schizophrenia
L Fredrik Jarskog, Jeffrey A Lieberman
The American Journal of Psychiatry
|
January 9, 2014
Response to Rosenfeld
L Fredrik Jarskog, T Scott Stroup
Evidence-Based Mental Health
|
August 23, 2011
Review: ziprasidone is marginally less effective than other atypical antipsychotics in people with schizophrenia
T Scott Stroup, L Fredrik Jarskog
Evidence-Based Mental Health
|
January 27, 2011
No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ
T Scott Stroup, L Fredrik Jarskog
Clinical Schizophrenia & Related Psychoses
|
September 26, 2012
New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?
Nobumi Miyake, Seiya Miyamoto, L Fredrik Jarskog
Journal of Psychiatric Research
|
July 30, 2014
New therapeutic approaches for treatment-resistant schizophrenia: a look to the future
Seiya Miyamoto, L Fredrik Jarskog, W Wolfgang Fleischhacker
Journal of Neuroimmunology
|
January 18, 2005
Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat
John H Gilmore, L Fredrik Jarskog, Swarooparani Vadlamudi
Journal of Neuroimmunology
|
May 14, 2003
Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat
John H Gilmore, L Fredrik Jarskog, Swarooparani Vadlamudi
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
Clinical Schizophrenia & Related Psychoses
|
September 26, 2012
Advantages and limitations of newer antipsychotics: evidence from large comparative trials
L Fredrik Jarskog
Current Opinion in Psychiatry
|
April 14, 2006
Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations
L Fredrik Jarskog
The Journal of Clinical Psychiatry
|
November 4, 2006
Neuroprotection in schizophrenia
L Fredrik Jarskog, Jeffrey A Lieberman
The American Journal of Psychiatry
|
January 9, 2014
Response to Rosenfeld
L Fredrik Jarskog, T Scott Stroup
Evidence-Based Mental Health
|
August 23, 2011
Review: ziprasidone is marginally less effective than other atypical antipsychotics in people with schizophrenia
T Scott Stroup, L Fredrik Jarskog
Evidence-Based Mental Health
|
January 27, 2011
No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ
T Scott Stroup, L Fredrik Jarskog
Clinical Schizophrenia & Related Psychoses
|
September 26, 2012
New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?
Nobumi Miyake, Seiya Miyamoto, L Fredrik Jarskog
Journal of Psychiatric Research
|
July 30, 2014
New therapeutic approaches for treatment-resistant schizophrenia: a look to the future
Seiya Miyamoto, L Fredrik Jarskog, W Wolfgang Fleischhacker
Journal of Neuroimmunology
|
January 18, 2005
Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat
John H Gilmore, L Fredrik Jarskog, Swarooparani Vadlamudi
Journal of Neuroimmunology
|
May 14, 2003
Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat
John H Gilmore, L Fredrik Jarskog, Swarooparani Vadlamudi
Page
of 8